Pluri Inc. (PLUR) Estados Financieros e Histórico

Pluri Inc. (PLUR) — Precio $1.14 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Pluri Inc. (PLUR): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Márgenes de los últimos 12 meses: margen bruto 19.0%, margen operativo -24.1%, margen neto -24.2%.

Al precio actual de $1.14, PLUR presenta beneficios negativos (P/E no significativo) y un ROE del 203.55%. La capitalización bursátil es de $12M.

Cuenta de Resultados (10 años)

Año2017201820192020202120222023202420252026
Ingresos0$50000$54000$230000$234000$287000$326000$1.3M$1.0M
Coste de Ventas$2.2M$2000$2000$1.6M$1.4M$1.1M$9000$4000$682000$563000
Beneficio Bruto-$2.2M$48000$52000-$1.5M-$1.4M-$819000$278000$322000$654000$453000
I+D$21.1M$22.6M$24.6M$20.1M$30.1M$24.4M$15.7M$12.4M$12.9M$15.3M
Generales y Administrativos$6.9M$11.2M$9.2M$7.8M$20.6M$17.4M$11.8M$10.0M$10.0M$10.3M
Gastos Operativos$28.0M$33.8M$35.6M$27.9M$49.3M$40.8M$27.5M$22.5M$22.8M$25.4M
Beneficio Operativo-$28.0M-$33.7M-$35.5M-$29.5M-$50.6M-$41.6M-$27.2M-$22.2M-$22.2M-$24.9M
EBITDA-$25.6M-$24.1M-$33.3M-$27.4M-$48.4M-$39.4M-$27.7M-$20.2M-$22.1M-$24.4M
Gastos por Intereses0$937000$29000$196000$78000$887000$843000$866000$873000-$932000
Beneficio Antes de Impuestos-$27.8M-$26.1M-$35.3M-$29.2M-$49.9M-$41.4M-$28.9M-$21.3M-$23.3M-$25.4M
Impuestos-$2050000-$9400000000-$5000-$25000
Beneficio Neto-$27.8M-$26.1M-$35.3M-$29.2M-$49.9M-$41.2M-$28.3M-$20.9M-$22.6M-$23.8M
BPA$-25.45$-19.74$-23.20$-12.80$-14.19$-10.24$-6.18$-3.99$-3.56$-2.44
BPA Diluido$-25.45$-19.74$-23.20$-12.80$-14.19$-10.24$-6.18$-3.99$-3.56$-2.44
Acciones en Circulación (Diluidas)$1.1M$1.3M$1.5M$2.3M$3.5M$4.0M$4.6M$5.2M$6.3M$9.7M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$316000$198000$167000$335000
Beneficio Bruto-$15000-$43000$56000$455000
Beneficio Operativo-$6.3M-$6.5M-$6.5M-$5.5M
EBITDA-$5.8M-$6.5M-$6.3M-$5.4M
Beneficio Neto-$5.8M-$6.5M-$6.2M-$5.9M
BPA$-0.65$-0.71$-0.55$-0.54
BPA Diluido$-0.65$-0.71$-0.55$-0.54

Balance (10 años)

Año2017201820192020202120222023202420252026
Caja y Equivalentes$4.7M$8.8M$4.1M$8.8M$31.2M$9.8M$5.4M$6.8M$5.9M$3.5M
Inversiones a Corto$21.4M$21.1M$19.6M$37.5M$33.7M$45.2M$34.8M$23.2M$14.7M$4.3M
Cuentas por Cobrar$1.2M$847000$1.4M$1.6M$1.5M$1.3M$527000$638000$722000$219000
Inventario00$6920000000000
Activos Corrientes$29.0M$32.0M$26.4M$48.5M$67.4M$57.7M$41.4M$31.1M$22.1M$8.7M
Inmovilizado Material$7.3M$5.7M$3.8M$3.8M$2.2M$9.0M$8.3M$7.2M$8.7M$7.7M
Fondo de Comercio00000000$3.1M$3.1M
Activos Intangibles00000000$2.8M$2.6M
Activos Totales$37.5M$39.0M$31.3M$65.5M$93.5M$68.1M$50.8M$39.5M$38.7M$24.9M
Cuentas por Pagar$2.0M$3.3M$2.3M$2.0M$2.5M$1.8M$1.8M$964000$866000$702000
Deuda a Corto000$1.0M0000$27.3M$27.4M
Pasivos Corrientes$5.4M$8.5M$8.2M$8.0M$11.5M$6.8M$5.6M$4.5M$32.3M$32.7M
Deuda a Largo0000$23.9M$21.7M$23.5M$24.0M00
Pasivos Totales$7.3M$10.5M$9.5M$9.4M$36.4M$35.9M$35.5M$34.1M$39.5M$42.3M
Reservas-$189.6M-$215.7M-$251.0M-$280.2M-$330.0M-$371.3M-$399.6M-$420.5M-$443.1M-$466.9M
Patrimonio Neto$30.3M$28.5M$21.8M$56.1M$57.2M$30.0M$13.4M$96000-$6.8M-$23.0M
Deuda Total000$1.6M$24.6M$28.8M$29.9M$29.6M$34.0M$34.9M
Deuda Neta-$26.1M-$29.9M-$23.7M-$44.8M-$40.4M-$26.2M-$10.3M-$373000$13.4M$27.1M
Capital Circulante$23.6M$23.5M$18.2M$40.5M$55.9M$50.9M$35.8M$26.7M-$10.2M-$24.0M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$4.7M$4.9M$3.6M$3.5M
Activos Totales$33.7M$30.6M$26.1M$24.9M
Pasivos Totales$39.3M$39.8M$39.1M$42.3M
Patrimonio Neto-$11.4M-$14.6M-$18.6M-$23.0M
Deuda Total$40.3M$40.8M$33.6M$34.9M

Flujo de Caja (10 años)

Año2017201820192020202120222023202420252026
Beneficio Neto-$27.8M-$26.1M-$35.3M-$29.2M-$49.9M-$41.4M-$28.9M-$21.3M-$23.2M-$25.4M
Amortizaciones$2.2M$2.0M$2.0M$1.6M$1.4M$1.1M$362000$253000$316000$511000
Compensación en Acciones$3.7M$6.5M$5.1M$2.6M$14.0M$8.9M$4.0M$2.6M$2.1M$3.7M
Cambio en Capital Circulante-$134000$3.7M-$1.3M-$1.3M$3.5M-$5.1M$1.7M-$21000$4.2M$1.6M
Flujo de Caja Operativo-$21.6M-$21.4M-$29.5M-$26.4M-$30.9M-$36.5M-$22.9M-$18.0M-$18.2M-$19.6M
Inversiones (CapEx)-$378000-$342000-$239000-$270000-$373000-$280000-$262000-$323000-$1.6M-$633000
Adquisiciones$30000-$1.9M$600000000$373000$18000
Recompra de Acciones0000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$22.0M-$21.7M-$29.7M-$26.6M-$31.3M-$36.8M-$23.1M-$18.3M-$19.8M-$20.2M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$5.4M-$5.2M-$4.5M-$4.4M
Inversiones (CapEx)-$116000-$447000-$44000-$26000
Flujo de Caja Libre-$5.5M-$5.7M-$4.6M-$4.5M
Dividendos Pagados0000
Compensación en Acciones$1.4M$763000$1.1M$476000

Crecimiento y Márgenes (10 años)

Año2017201820192020202120222023202420252026
Crecimiento Ingresos (anual)+8.0%-57.4%-100.0%+22.6%+13.6%+309.8%-24.0%
Crecimiento Beneficio Neto (anual)+6.1%-35.1%+17.4%-71.1%+17.3%+31.3%+26.2%-8.1%-5.5%
Crecimiento BPA (anual)+22.4%-17.5%+44.8%-10.9%+27.8%+39.6%+35.4%+10.8%+31.5%
Cambio en Acciones (anual)+21.0%+16.6%+47.5%+54.5%+14.5%+13.9%+14.4%+20.9%+53.8%
Crecimiento FCF (anual)+1.2%-36.7%+10.3%-17.4%-17.6%+37.1%+20.7%-8.1%-2.0%
Margen Bruto96.0%96.3%-6726.1%-350.0%96.9%98.8%49.0%44.6%
Margen Operativo-67462.0%-65800.0%-128156.5%-17774.8%-9493.4%-6796.9%-1659.9%-2454.5%
Margen EBITDA-48216.0%-61750.0%-119069.6%-16852.1%-9645.3%-6204.0%-1651.6%-2404.2%
Margen Neto-52252.0%-65383.3%-126747.8%-17624.8%-9867.9%-6407.4%-1690.3%-2344.6%
Margen FCF-43444.0%-54985.2%-115821.7%-15718.4%-8055.4%-5627.0%-1484.2%-1990.3%
Tasa Impositiva Efectiva0.7%-0.0%0.3%-0.0%-0.0%-0.0%-0.0%-0.0%0.0%0.1%

Datos por Acción (10 años)

Año2017201820192020202120222023202420252026
FCF por Acción$-20.12$-16.42$-19.26$-11.71$-8.90$-9.14$-5.05$-3.50$-3.13$-2.08
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$1.1M$1.3M$1.5M$2.3M$3.5M$4.0M$4.6M$5.2M$6.3M$9.7M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital203.55%
Rentabilidad sobre capital invertido-117.79%
Rentabilidad sobre activos-100.41%
Margen bruto19.00%
Margen operativo-2412.14%
Margen neto-2424.75%

Salud financiera

Deuda / Patrimonio-1.81
Ratio corriente0.33
Piotroski F-Score3
Altman Z-Score-17.73

Ratios Clave (10 años)

Año2017201820192020202120222023202420252026
P/E-4.02-4.94-2.03-5.52-2.23-0.96-1.04-1.44-1.39-0.86
P/VC3.704.533.342.871.951.322.20314.40-4.58-0.88
P/V0.002582.501347.826995.130.00169.21102.1892.5823.4820.04
Margen Bruto0.0%96.0%96.3%-6726.1%0.0%-350.0%96.9%98.8%49.0%44.6%
Margen Operativo0.0%-67462.0%-65800.0%-128156.5%0.0%-17774.8%-9493.4%-6796.9%-1659.9%-2454.5%
Margen Neto0.0%-52252.0%-65383.3%-126747.8%0.0%-17624.8%-9867.9%-6407.4%-1690.3%-2344.6%

Empresas relacionadas: ANTX · BOLD · IBIO · INTS · ITRM · JSPR · NXTC

Explorar sector: Healthcare · Biotechnology

Más secciones de PLUR: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones